EVOLVING STRATEGIES FOR THE TREATMENT OF MYELOMATOSIS
- 1 December 1994
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 88 (4) , 672-678
- https://doi.org/10.1111/j.1365-2141.1994.tb05103.x
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Multiple myeloma. New approaches to therapyJAMA, 1993
- A randomized multicentric study comparing alternating combination chemotherapy (VCMP/VBAP) and melphalan-prednisone in multiple myelomaAnnals of Hematology, 1990
- Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction ChemotherapyNew England Journal of Medicine, 1990
- INFUSION OF VINCRISTINE AND DOXORUBICIN WITH ORAL DEXAMETHASONE AS FIRST-LINE THERAPY FOR MULTIPLE MYELOMAThe Lancet, 1989
- Pulsed high dose oral prednisolone in relapsed or refractory multiple myelomaHematological Oncology, 1989
- Recombinant interferon alfa-2C versus polychemotherapy (VMCP) for treatment of multiple myeloma: a prospective randomized trialEuropean Journal of Cancer and Clinical Oncology, 1986
- Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating AgentsNew England Journal of Medicine, 1984
- Relative importance of renal failure and increased bone resorption in the hypercalcaemia of myelomatosis.Journal of Clinical Pathology, 1981
- Smoldering Multiple MyelomaNew England Journal of Medicine, 1980
- INTERFERON THERAPY IN MYELOMATOSISThe Lancet, 1979